BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1512 related articles for article (PubMed ID: 16207572)

  • 41. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current management of refractory ascites in patients with cirrhosis.
    Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
    J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
    Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N; Sanyal AJ
    Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pathophysiologic basis for the treatment of cirrhotic ascites.
    Wong F; Blendis L
    Clin Liver Dis; 2001 Aug; 5(3):819-32. PubMed ID: 11565142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ascites: pathogenesis and therapeutic principles.
    Møller S; Henriksen JH; Bendtsen F
    Scand J Gastroenterol; 2009; 44(8):902-11. PubMed ID: 19479632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of surgical therapy in the treatment of refractory ascites].
    Pisani Ceretti A; Intra M; Borzio M; Santambrogio R; Opocher E; Ballarini C; Cordovana A; Motta R; Spina GP
    Minerva Chir; 1997 Nov; 52(11):1339-48. PubMed ID: 9489332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of ascites in children.
    Lane ER; Hsu EK; Murray KF
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1281-92. PubMed ID: 26325252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and treatment of ascites.
    Tsochatzis EA; Gerbes AL
    J Hepatol; 2017 Jul; 67(1):184-185. PubMed ID: 28119010
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of ascites.
    Yu AS; Hu KQ
    Clin Liver Dis; 2001 May; 5(2):541-68, viii. PubMed ID: 11385975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
    Moore KP; Wong F; Gines P; Bernardi M; Ochs A; Salerno F; Angeli P; Porayko M; Moreau R; Garcia-Tsao G; Jimenez W; Planas R; Arroyo V
    Hepatology; 2003 Jul; 38(1):258-66. PubMed ID: 12830009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of ascites. A review.
    Watanabe A
    J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Refractory ascites: definition, pathogenesis and treatment.
    Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
    Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of refractory ascites and hepatorenal syndrome.
    Sussman AN; Boyer TD
    Curr Gastroenterol Rep; 2011 Feb; 13(1):17-25. PubMed ID: 21080246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
    Shao J; Zhang L; Han GH; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):721-723. PubMed ID: 27938554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.